Ultrasonic Vaporizing Tip for Portable Inhalation Therapy

Solution Overview

Problem

Conventional nebulizers for inhalation therapy are not portable and require connection to power, limiting their application and portability, especially for temperature-sensitive medications and therapies that cannot withstand heating or combustion.

Innovation Solution

A portable vaporizing apparatus using an ultrasonic activating tip with piezoelectric transducers to convert liquid therapeutic substances into aerosols at room temperature, without heating or combustion, allowing for the administration of temperature-sensitive drugs and tobacco inhalants through a compact, non-combusting device.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If conventional nebulizers are used for inhalation therapy, then aerosol generation capability is achieved, but portability is limited and fixed place operation is required

Engineering Contradiction:
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The patent replaces conventional mechanical nebulization systems with an ultrasonic vibration-based aerosol generation system. The ultrasonic activating tip uses high-frequency vibrations to atomize liquid therapeutic substances into aerosols, eliminating the need for complex mechanical compressors and power connections required by conventional nebulizers, thereby achieving true portability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the operating parameters by using ultrasonic frequency vibrations (typically 20-100 kHz) to generate aerosols. This parameter change allows the system to operate at room temperature without requiring external power sources or complex mechanical systems, enabling portable operation while maintaining effective aerosol generation for inhalation therapy.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If heating or combustion methods are used for vaporization, then vapor generation is achieved, but temperature-sensitive medications are damaged

Engineering Contradiction:
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent substitutes thermal vaporization methods with ultrasonic vibration-based atomization. The ultrasonic activating tip generates aerosols through high-frequency mechanical vibrations rather than heating, allowing temperature-sensitive medications to be vaporized without thermal damage. This maintains vapor generation efficiency while eliminating harmful thermal effects.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent utilizes phase transition through ultrasonic vibration to convert liquid therapeutic substances directly into aerosol particles. The ultrasonic energy provides the mechanical force needed for liquid-to-aerosol phase change without requiring temperature increase, enabling efficient vapor generation while preserving temperature-sensitive medication properties.

Inventive Principle:
Principle #36Phase transitions

3Ease of operation

If conventional apparatus are used, then aerosol therapy delivery is achieved, but portability is limited

Engineering Contradiction:
Core Design Contradiction:
Ease of operationVSUse of energy by moving object

Solution Approach 1:

The patent replaces power-intensive mechanical nebulization systems with ultrasonic vibration-based aerosol generation. The ultrasonic activating tip requires minimal energy input compared to conventional compressors, enabling portable operation without large power sources. This substitution dramatically reduces power consumption while maintaining effective aerosol therapy delivery.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables efficient, portable delivery of aerosolized therapeutic substances directly to the lungs, avoiding cancer-causing agents and allowing for the administration of temperature-sensitive medications and tobacco leaf ingredients in a safe, non-combusting manner.

Implementation Method 1

ultrasonic activating tip with piezoelectric transducers to convert liquid therapeutic substances into aerosols

Methodology Applied
Scientific EffectPiezoelectric effect: Piezoelectric Effect

Implementation Method 2

agitates ultrasonic waves in the ultrasonic activating tip using the received power

Methodology Applied
Scientific EffectUltrasonic vibration: Ultrasonic Vibration

Implementation Method 3

uses sonication energy to convert liquids to aerosols

Methodology Applied
Scientific EffectSonication: Sonochemistry

Implementation Method 4

vaporizes the therapeutic substance comprised in the liquid cartridge, based on the agitated ultrasonic waves and the ambient air

Methodology Applied
Scientific EffectVaporization: Evaporation

Implementation Method 5

creates an aerosol from the vaporized the therapeutic substance, to pass into the mouthpiece for breathing into an airway of a user

Methodology Applied
Scientific EffectAerosol formation: Aerosol

Data Source

PatentUS20220279842A1Portable vaporizing apparatus and a method thereof
Publication Date: 2022.09.08
  • US20220279842A1 patent drawing
  • US20220279842A1 patent drawing
  • US20220279842A1 patent drawing

AI summary

A portable vaporizing apparatus for inhalation therapy and method of operation of the portable vaporizing apparatus are disclosed. The portable vaporizing apparatus includes a liquid cartridge comprising therapeutic substance, and ultrasonic activating tip removably coupled to proximal end of liquid cartridge. Furthermore, portable vaporizing apparatus includes mouthpiece having airflow outlet removably coupled to outer edge of proximal end of liquid cartridge. Thereafter, portable vaporizing apparatus includes power source removably coupled to distal end of liquid cartridge. The portable vaporizing apparatus receives ambient air via mouthpiece and power from power source to liquid cartridge. Further, portable vaporizing apparatus agitates ultrasonic waves in ultrasonic activating tip using received power.Furthermore, portable vaporizing apparatus vaporizes therapeutic substance comprised in liquid cartridge, based on agitated ultrasonic waves and ambient air. Also, portable vaporizing apparatus creates aerosol from vaporized therapeutic substance, to pass into mouthpiece for breathing into airway of user.